The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
AT-403
BTRX-246040
Cebranopadol
GRT-6010
GRTTA-2210
Others

Segment by Application
Diabetic Neuropathic Pain
Drug Addiction
Major Depressive Disorder
Postherpetic Neuralgia
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

By Company
Blackthorn Therapeutics Inc
Fuso Pharmaceutical Industries Ltd
Grunenthal GmbH
Orexigen Therapeutics Inc
Serodus ASA